Lymphoma Association Looking for East Anglia Bicyclists

On June 13, 2009 the Lymphoma Association will be holding its annual bike ride fundraiser and they're looking for cyclists.

The 2009 Lymphoma Association Bike Ride is a two-day, 150 mile event that starts and ends in the city of Norwich and includes one overnight stay in Ipswich.

In order to participate, riders must pay a £120 registration fee and raise a minimum £300 in sponsorship donations.

For participating, riders get:

  • --Two night's dinner, bed and breakfast
  • --Lunch on Saturday June 13 and Sunday June 14
  • --Drinks and chocolate
  • --Route maps
  • --A Lymphoma Association T-shirt

Proceeds go to the Lymphoma Association, the "only specialist UK charity that provides accurate medical information and support to lymphatic cancer patients, their families and friends." It was originally founded in 1986.

If interested, contact the Lymphoma Association fundraising team by phone (01296 619419) or email (fundraising@lymphomas.org.uk). You can also download an application form at www.lymphomas.org.uk.

Blog Category: 

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap